Investment
Features
FeesSafety
Academy
More
Pluang+

Compare US Bancorp (USB) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

US BancorpTrade
DENTSPLY SIRONA IncTrade

Price performance (Past 24H)

Key statistics

US Bancorp vs DENTSPLY SIRONA Inc — how do they compare? US Bancorp trades at $56.58 (market cap $88.86B), while DENTSPLY SIRONA Inc trades at $8.61 (market cap $1.73B). The key difference: US Bancorp is far larger — about 51.4× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals — on Pluang, investors hold US Bancorp for 97 Days and DENTSPLY SIRONA Inc for 72 Days on average.

USBXRAY
Market Cap
$88.86B$1.73B
Volume
8,869,9936,198,582
Sector
FinancialsHealth
52-Week High
$65.42$14.68
52-Week Low
$45.28$8.52
Typical Hold Time
97 Days72 Days
Enterprise Value
$118.35B$3.80B
Dividend Yield
3.79%5.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

US Bancorp

U.S. Bancorp (USB) trades at $56.17, down 1.95% with bearish technical signals but strong fundamentals including consistent earnings beats and a 27.61% net margin. The stock offers a $2.16 annual dividend yield with recent 3.8% increase. Analyst consensus is bullish with $69.94 price target despite near-term technical weakness.

USB presents a value opportunity with attractive P/E of 11.38 and strong profitability metrics, though investors face interest rate sensitivity and regulatory uncertainty risks. The bank's solid earnings track record and dividend growth support long-term investment case despite current bearish technical indicators.

DENTSPLY SIRONA Inc

DENTSPLY SIRONA (XRAY) trades at $8.54, near its 52-week low, with bearish technical indicators and mixed fundamentals. The company reported Q2 2026 EPS of $0.52 beating expectations but revenue declined 4.1% year-over-year. Net income remains negative at -$598 million for 2025, though margins show slight improvement. Analyst consensus is mixed with 37.5% buy ratings but a $13.40 price target suggesting 57% upside potential from current levels.

The stock presents a high-risk turnaround opportunity with significant upside if management's restructuring efforts succeed, but faces headwinds from declining sales, margin pressure, and competitive challenges in dental markets. Institutional ownership changes and ongoing transformation investments create both uncertainty and potential for recovery.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

USB
28% Buy72% Sell
Avg holding period · 97 Days
XRAY

No sentiment data available yet.

Top news

Latest headlines on both assets

About US Bancorp

As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.

Read more on USB →

About DENTSPLY SIRONA Inc

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters

Read more on XRAY →